USPTO serial 87372427
FLUOTAG
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 10, 2018
- Examiner
- LOTT, MAUREEN DALL
- Law office
- Historical data usage
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with FLUOTAG?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ryan D. Artis
Ryan D. Artis RIVERSIDE LAW LLP175 Strafford AveSuite 100WAYNE, PA 19087Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical reagents for scientific or industrial purposes and not for medical or veterinary use, namely, chemical reagents containing antibodies or proteins having antibody-like properties; Chemical reagents for scientific or industrial purposes and not for medical or veterinary use, namely, for microscopy, flow cytometry, western blot, imaging, fluorescence based analysis, or tissue analysis; Diagnostic or analytical kits other than for medical or veterinary use containing chemical reagents containing antibodies or proteins having antibody-like properties; Diagnostic or analytical kits other than for medical or veterinary use containing chemical reagents for microscopy, flow cytometry, western blot, imaging, fluorescence based analysis, or tissue analysis | ACTIVE | — |
| 005 | Pharmaceutical and veterinary preparations containing antibodies, all for use in treating cancer; Pharmaceutical and veterinary preparations containing antibodies, all for use in treating autoimmune diseases; Pharmaceutical and veterinary preparations containing antibodies, all for use in treating infectious diseases; Pharmaceutical and veterinary preparations containing antibodies, all for use in treating inflammatory diseases; Pharmaceutical and veterinary preparations containing proteins having antibody-like properties, all for use in treating cancer; Pharmaceutical and veterinary preparations containing proteins having antibody-like properties, all for use in treating autoimmune diseases; Pharmaceutical and veterinary preparations containing proteins having antibody-like properties, all for use in treating infectious diseases; Pharmaceutical and veterinary preparations containing proteins having antibody-like properties, all for use in treating inflammatory diseases; Diagnostic preparations for medical or veterinary purposes, namely preparations containing antibodies or proteins having antibody-like properties [ ; Drugs being pharmaceutical preparations containing antibodies, all for use in treating cancer; Drugs being pharmaceutical preparations containing antibodies, all for use in treating autoimmune diseases; Drugs being pharmaceutical preparations containing antibodies, all for use in treating infectious diseases; Drugs being pharmaceutical preparations containing antibodies, all for use in treating inflammatory diseases; Drugs being pharmaceutical preparations containing proteins having antibody-like properties, all for use in treating cancer; Drugs being pharmaceutical preparations containing proteins having antibody-like properties, all for use in treating autoimmune diseases; Drugs being pharmaceutical preparations containing proteins having antibody-like properties, all for use in treating infectious diseases; Drugs being pharmaceutical preparations containing proteins having antibody-like properties, all for use in treating inflammatory diseases; Vaccines containing antibodies; Vaccines containing proteins having antibody-like properties ] | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by NanoTag Biotechnologies GmbH
- Other trademarks owned by NanoTag Biotechnologies GmbH
- Other trademarks owned by NanoTag Biotechnologies GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Similar marks named FLUOTAG
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 30, 2024 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Sep 30, 2024 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Sep 26, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 22, 2024 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Apr 10, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Apr 10, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 23, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 23, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 3, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 7, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 7, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 7, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 7, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 9, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 9, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 9, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 8, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 21, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 18, 2017 | NWAP | NEW APPLICATION ENTERED | — |